Healthcare/ Biotech Financials qn
Is there any possible way to obtain numbers for failed R&D for public pharmaceutical firms? And if so, any way to obtain a breakdown of those numbers, potentially by product lines? I seem to be only obtaining impairment values, and due to lack of familiarity with the industry, I'm unsure as to whether those numbers would serve as sufficient proxy for failed R&D.
Also what's the typical neighborhood of numbers for the above? Just to use as a rough benchmark to compare against.
My Name is Jeff, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
If those topics were completely useless, don't blame me, blame my programmers...
Et tempore ab quae maxime facilis sit. Et perspiciatis cumque beatae debitis. Quas et dicta quas blanditiis. Dolorem nisi sunt iste dignissimos. Voluptatum labore harum numquam cum molestias quaerat quaerat. Temporibus sed debitis neque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...